Hyperamylasemia is not Associated with Dipeptidyl Peptidase 4 Inhibitors in South Indian Adults with Type 2 Diabetes Mellitus

INTRODUCTION: Although not definitive, there is small increased risk of acute pancreatitis with the use of dipeptidyl peptidase 4 inhibitors (DPP4i). Hence, there is an interest in the elevation of pancreatic enzymes among type 2 diabetes mellitus (T2DM) patients using DPP4i. However, the studies re...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarathi, Vijaya, Tirupati, Sunanda, Sabinkar, Gayatri, Mohan, Rama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443446/
https://www.ncbi.nlm.nih.gov/pubmed/37614844
http://dx.doi.org/10.4103/ijabmr.ijabmr_503_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443446/
https://www.ncbi.nlm.nih.gov/pubmed/37614844
http://dx.doi.org/10.4103/ijabmr.ijabmr_503_22

Ejemplares similares